The market for recombinant parvovirus antigens is expected to grow at a compound annual growth rate (CAGR) of about 5% between 2023 and 2029.Recombinant parvovirus antigens are used in numerous diagnostic and investigative procedures involving parvovirus infection. Due to the increased prevalence of parvovirus infections and the rising demand for efficient diagnostic processes, the global market for recombinant parvovirus antigens is predicted to experience substantial expansion in the coming years.
The market is expected to be boosted by rising R&D expenditures connected to parvovirus infections as well as rising attention to the creation of novel diagnostic and therapeutic strategies. Also, as more recombinant parvovirus antigens are utilised in veterinary applications, the market is anticipated to grow.
Recombinant Parvovirus Antigens Market Segment Overview The global Recombinant Parvovirus Antigens market is segmented based on By Type, Application, and Region.
*All our reports are customizable as per customer requirementsThis study forecasts revenue and volume growth at global, regional, and country levels from 2018 to 2029. Global Recombinant Parvovirus Antigens market is distributed on the basis of the below-mentioned segments:
Recombinant Parvovirus Antigens Market, By type
· Antigen NS1
· Antigen VP1
· Antigen VP2
· Others
Recombinant Parvovirus Antigens Market, By Application
· Hospital
. Diagnostic Laboratory
· Others
Recombinant Parvovirus Antigens Market Regional OverviewIn terms of region, Asia Pacific is the prominent region for the global Recombinant Parvovirus Antigens market. The widespread use of fatty acid esters in the food industry may support Asia Pacific countries to grow at a significant rate. The increasing demand from the Medical Care industries is estimated to boost the market for Recombinant Parvovirus Antigens in not only the Asia Pacific but also the North American region. North America represented a major share of the global market and the pattern is foreseen to continue in the upcoming years as well. Additionally, the European market had held a decent share in the fatty acid esters market.
Recombinant Parvovirus Antigens Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Recombinant Parvovirus Antigens Market, Key Players· ELlTechGroup
· Diesse Diagnostica Senese
· R-Biopharm AG
· Zoetis
· altona Diagnostics GmbH
Report Scope
| Report Metric |
Details |
| Market size available for years |
2023–2029 |
| Base year considered |
2022 |
| Forecast period |
2023–2029 |
| Forecast unit |
Value (USD Billion) |
| Segments Covered |
By type (Antigen NS1,Antigen VP1,Antigen VP2 and others)
By Application (Hospital,Diagnostic Laboratory and Others) |
| Regions covered |
North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered |
ELlTechGroup,Diesse Diagnostica Senese,R-Biopharm AG,Zoetis,altona Diagnostics GmbH |
List of Figures
Figure 1: Global Recombinant Parvovirus Antigens Market Revenue Breakdown (USD Billion, %) by Region, 2022 & 2029
Figure 2: Global Recombinant Parvovirus Antigens Market Value Share (%), By Segment 1, 2022 & 2029
Figure 3: Global Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 4: Global Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 5: Global Recombinant Parvovirus Antigens Market Value Share (%), By Segment 2, 2022 & 2029
Figure 6: Global Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 7: Global Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 8: Global Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 9: Global Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Others, 2018-2029
Figure 10: Global Recombinant Parvovirus Antigens Market Value Share (%), By Segment 3, 2022 & 2029
Figure 11: Global Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 12: Global Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 13: Global Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 14: Global Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Others, 2018-2029
Figure 15: Global Recombinant Parvovirus Antigens Market Value (USD Billion), by Region, 2022 & 2029
Figure 16: North America Recombinant Parvovirus Antigens Market Value Share (%), By Segment 1, 2022 & 2029
Figure 17: North America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 18: North America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 19: North America Recombinant Parvovirus Antigens Market Value Share (%), By Segment 2, 2022 & 2029
Figure 20: North America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 21: North America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 22: North America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 23: North America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Others, 2018-2029
Figure 24: North America Recombinant Parvovirus Antigens Market Value Share (%), By Segment 3, 2022 & 2029
Figure 25: North America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 26: North America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 27: North America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 28: North America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Others, 2018-2029
Figure 29: North America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by U.S., 2018-2029
Figure 30: North America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Canada, 2018-2029
Figure 31: Latin America Recombinant Parvovirus Antigens Market Value Share (%), By Segment 1, 2022 & 2029
Figure 32: Latin America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 33: Latin America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 34: Latin America Recombinant Parvovirus Antigens Market Value Share (%), By Segment 2, 2022 & 2029
Figure 35: Latin America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 36: Latin America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 37: Latin America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 38: Latin America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Others, 2018-2029
Figure 39: Latin America Recombinant Parvovirus Antigens Market Value Share (%), By Segment 3, 2022 & 2029
Figure 40: Latin America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 41: Latin America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 42: Latin America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 43: Latin America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Others, 2018-2029
Figure 44: Latin America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Brazil, 2018-2029
Figure 45: Latin America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Mexico, 2018-2029
Figure 46: Latin America Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Rest of Latin America, 2018-2029
Figure 47: Europe Recombinant Parvovirus Antigens Market Value Share (%), By Segment 1, 2022 & 2029
Figure 48: Europe Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 49: Europe Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 50: Europe Recombinant Parvovirus Antigens Market Value Share (%), By Segment 2, 2022 & 2029
Figure 51: Europe Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 52: Europe Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 53: Europe Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 54: Europe Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Others, 2018-2029
Figure 55: Europe Recombinant Parvovirus Antigens Market Value Share (%), By Segment 3, 2022 & 2029
Figure 56: Europe Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 57: Europe Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 58: Europe Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 59: Europe Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Others, 2018-2029
Figure 60: Europe Recombinant Parvovirus Antigens Market Forecast (USD Billion), by U.K., 2018-2029
Figure 61: Europe Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Germany, 2018-2029
Figure 62: Europe Recombinant Parvovirus Antigens Market Forecast (USD Billion), by France, 2018-2029
Figure 63: Europe Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Italy, 2018-2029
Figure 64: Europe Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Spain, 2018-2029
Figure 65: Europe Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Russia, 2018-2029
Figure 66: Europe Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Rest of Europe, 2018-2029
Figure 67: Asia Pacific Recombinant Parvovirus Antigens Market Value Share (%), By Segment 1, 2022 & 2029
Figure 68: Asia Pacific Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 69: Asia Pacific Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 70: Asia Pacific Recombinant Parvovirus Antigens Market Value Share (%), By Segment 2, 2022 & 2029
Figure 71: Asia Pacific Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 72: Asia Pacific Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 73: Asia Pacific Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 74: Asia Pacific Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Others, 2018-2029
Figure 75: Asia Pacific Recombinant Parvovirus Antigens Market Value Share (%), By Segment 3, 2022 & 2029
Figure 76: Asia Pacific Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 77: Asia Pacific Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 78: Asia Pacific Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 79: Asia Pacific Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Others, 2018-2029
Figure 80: Asia Pacific Recombinant Parvovirus Antigens Market Forecast (USD Billion), by China, 2018-2029
Figure 81: Asia Pacific Recombinant Parvovirus Antigens Market Forecast (USD Billion), by India, 2018-2029
Figure 82: Asia Pacific Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Japan, 2018-2029
Figure 83: Asia Pacific Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Australia, 2018-2029
Figure 84: Asia Pacific Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Southeast Asia, 2018-2029
Figure 85: Asia Pacific Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Rest of Asia Pacific, 2018-2029
Figure 86: Middle East & Africa Recombinant Parvovirus Antigens Market Value Share (%), By Segment 1, 2022 & 2029
Figure 87: Middle East & Africa Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 88: Middle East & Africa Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 89: Middle East & Africa Recombinant Parvovirus Antigens Market Value Share (%), By Segment 2, 2022 & 2029
Figure 90: Middle East & Africa Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 91: Middle East & Africa Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 92: Middle East & Africa Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 93: Middle East & Africa Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Others, 2018-2029
Figure 94: Middle East & Africa Recombinant Parvovirus Antigens Market Value Share (%), By Segment 3, 2022 & 2029
Figure 95: Middle East & Africa Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 96: Middle East & Africa Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 97: Middle East & Africa Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 98: Middle East & Africa Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Others, 2018-2029
Figure 99: Middle East & Africa Recombinant Parvovirus Antigens Market Forecast (USD Billion), by GCC, 2018-2029
Figure 100: Middle East & Africa Recombinant Parvovirus Antigens Market Forecast (USD Billion), by South Africa, 2018-2029
Figure 101: Middle East & Africa Recombinant Parvovirus Antigens Market Forecast (USD Billion), by Rest of Middle East & Africa, 2018-2029
List of Tables
Table 1: Global Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Segment 1, 2018-2029
Table 2: Global Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Segment 2, 2018-2029
Table 3: Global Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Segment 3, 2018-2029
Table 4: Global Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Region, 2018-2029
Table 5: North America Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Segment 1, 2018-2029
Table 6: North America Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Segment 2, 2018-2029
Table 7: North America Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Segment 3, 2018-2029
Table 8: North America Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Country, 2018-2029
Table 9: Europe Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Segment 1, 2018-2029
Table 10: Europe Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Segment 2, 2018-2029
Table 11: Europe Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Segment 3, 2018-2029
Table 12: Europe Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Country, 2018-2029
Table 13: Latin America Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Segment 1, 2018-2029
Table 14: Latin America Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Segment 2, 2018-2029
Table 15: Latin America Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Segment 3, 2018-2029
Table 16: Latin America Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Country, 2018-2029
Table 17: Asia Pacific Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Segment 1, 2018-2029
Table 18: Asia Pacific Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Segment 2, 2018-2029
Table 19: Asia Pacific Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Segment 3, 2018-2029
Table 20: Asia Pacific Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Country, 2018-2029
Table 21: Middle East & Africa Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Segment 1, 2018-2029
Table 22: Middle East & Africa Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Segment 2, 2018-2029
Table 23: Middle East & Africa Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Segment 3, 2018-2029
Table 24: Middle East & Africa Recombinant Parvovirus Antigens Market Revenue (USD Billion) Forecast, by Country, 2018-2029
Research Process
Data Library Research are conducted by industry experts who offer insight on
industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager
and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Primary Research
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary Research
Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size Estimation
Both, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
